Literature DB >> 23658252

Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors.

Ilda Theka1, Massimiliano Caiazzo, Elena Dvoretskova, Damiana Leo, Federica Ungaro, Sebastiano Curreli, Francesca Managò, Maria Teresa Dell'Anno, Gianni Pezzoli, Raul R Gainetdinov, Alexander Dityatev, Vania Broccoli.   

Abstract

Current protocols for in vitro differentiation of human induced pluripotent stem cells (hiPSCs) to generate dopamine (DA) neurons are laborious and time-expensive. In order to accelerate the overall process, we have established a fast protocol by expressing the developmental transcription factors ASCL1, NURR1, and LMX1A. With this method, we were able to generate mature and functional dopaminergic neurons in as few as 21 days, skipping all the intermediate steps for inducting and selecting embryoid bodies and rosette-neural precursors. Strikingly, the resulting neuronal conversion process was very proficient, with an overall efficiency that was more than 93% of all the coinfected cells. hiPSC-derived DA neurons expressed all the critical molecular markers of the DA molecular machinery and exhibited sophisticated functional features including spontaneous electrical activity and dopamine release. This one-step protocol holds important implications for in vitro disease modeling and is particularly amenable for exploitation in high-throughput screening protocols.

Entities:  

Keywords:  Direct cell conversion; Dopamine; Neuron; Pluripotent stem cells; Reprogramming

Mesh:

Substances:

Year:  2013        PMID: 23658252      PMCID: PMC3673759          DOI: 10.5966/sctm.2012-0133

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  24 in total

1.  Functional integration of dopaminergic neurons directly converted from mouse fibroblasts.

Authors:  Jongpil Kim; Susan C Su; Haoyi Wang; Albert W Cheng; John P Cassady; Michael A Lodato; Christopher J Lengner; Chee-Yeun Chung; Meelad M Dawlaty; Li-Huei Tsai; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2011-10-20       Impact factor: 24.633

2.  Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Authors:  Neeta S Roy; Carine Cleren; Shashi K Singh; Lichuan Yang; M Flint Beal; Steven A Goldman
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

3.  Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

Authors:  Oliver Cooper; Gunnar Hargus; Michela Deleidi; Alexandra Blak; Teresia Osborn; Elizabeth Marlow; Kristen Lee; Adam Levy; Eduardo Perez-Torres; Alyssa Yow; Ole Isacson
Journal:  Mol Cell Neurosci       Date:  2010-07-24       Impact factor: 4.314

4.  Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells.

Authors:  Cristina Gómez-Santos; Isidre Ferrer; Antonio F Santidrián; Marta Barrachina; Joan Gil; Santiago Ambrosio
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

5.  Derivation of midbrain dopamine neurons from human embryonic stem cells.

Authors:  Anselme L Perrier; Viviane Tabar; Tiziano Barberi; Maria E Rubio; Juan Bruses; Norbert Topf; Neil L Harrison; Lorenz Studer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

6.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells.

Authors:  Kiichi Watanabe; Morio Ueno; Daisuke Kamiya; Ayaka Nishiyama; Michiru Matsumura; Takafumi Wataya; Jun B Takahashi; Satomi Nishikawa; Shin-ichi Nishikawa; Keiko Muguruma; Yoshiki Sasai
Journal:  Nat Biotechnol       Date:  2007-05-27       Impact factor: 54.908

Review 7.  The genetics of Parkinson's syndromes: a critical review.

Authors:  John Hardy; Patrick Lewis; Tamas Revesz; Andrew Lees; Coro Paisan-Ruiz
Journal:  Curr Opin Genet Dev       Date:  2009-05-04       Impact factor: 5.578

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.

Authors:  Massimiliano Caiazzo; Maria Teresa Dell'Anno; Elena Dvoretskova; Dejan Lazarevic; Stefano Taverna; Damiana Leo; Tatyana D Sotnikova; Andrea Menegon; Paola Roncaglia; Giorgia Colciago; Giovanni Russo; Piero Carninci; Gianni Pezzoli; Raul R Gainetdinov; Stefano Gustincich; Alexander Dityatev; Vania Broccoli
Journal:  Nature       Date:  2011-07-03       Impact factor: 49.962

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  38 in total

Review 1.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

2.  Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays.

Authors:  Silvia Ronchi; Alessio Paolo Buccino; Gustavo Prack; Sreedhar Saseendran Kumar; Manuel Schröter; Michele Fiscella; Andreas Hierlemann
Journal:  Adv Biol (Weinh)       Date:  2021-01-14

Review 3.  Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Authors:  I K Rony; A Baten; J A Bloomfield; M E Islam; M M Billah; K D Islam
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

Review 4.  An update on stem cell biology and engineering for brain development.

Authors:  C J C Parr; S Yamanaka; H Saito
Journal:  Mol Psychiatry       Date:  2017-04-04       Impact factor: 15.992

Review 5.  Investigating human disease using stem cell models.

Authors:  Jared L Sterneckert; Peter Reinhardt; Hans R Schöler
Journal:  Nat Rev Genet       Date:  2014-07-29       Impact factor: 53.242

Review 6.  Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems.

Authors:  Kristina Rehbach; Michael B Fernando; Kristen J Brennand
Journal:  J Neurosci       Date:  2020-02-05       Impact factor: 6.167

7.  Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.

Authors:  Eva Vergaño-Vera; Eva Díaz-Guerra; Eva Rodríguez-Traver; Héctor R Méndez-Gómez; Óscar Solís; Jaime Pignatelli; James Pickel; Sang-Hun Lee; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Dev Neurobiol       Date:  2014-12-10       Impact factor: 3.964

Review 8.  Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.

Authors:  S K Powell; J Gregory; S Akbarian; K J Brennand
Journal:  Mol Cell Neurosci       Date:  2017-05-23       Impact factor: 4.314

Review 9.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

10.  Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.

Authors:  Eva Rodríguez-Traver; Oscar Solís; Eva Díaz-Guerra; Óscar Ortiz; Eva Vergaño-Vera; Héctor R Méndez-Gómez; Patricia García-Sanz; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Neurotox Res       Date:  2015-12-17       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.